FDA.reportPublic FDA data

Application 061621

Type
ANDA
Sponsor
ARBOR PHARMS LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ERYTHROMYCINERYTHROMYCINTABLET;ORAL250MGNoNo
002ERYTHROMYCINERYTHROMYCINTABLET;ORAL500MGNoYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
21695-387ERYTHROMYCIN Base FilmtabERYTHROMYCINRebel Distributors CorpANDACurrent
21695-389ERYTHROMYCIN Base FilmtabERYTHROMYCINRebel Distributors CorpANDACurrent
21695-457ERY-TABerythromycinRebel Distributors CorpANDACurrent
24338-102ErythromycinErythromycinArbor Pharmaceuticals, Inc.ANDACurrent
24338-104ErythromycinErythromycinArbor Pharmaceuticals, Inc.ANDACurrent
50090-0361ErythromycinErythromycinA-S Medication SolutionsANDACurrent
50090-0361ErythromycinErythromycinA-S Medication SolutionsANDACurrent
52536-103ErythromycinErythromycinWilshire PharmaceuticalsANDACurrent
52536-105ErythromycinErythromycinWilshire PharmaceuticalsANDACurrent
55289-025ErythromycinErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-025ErythromycinErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-025ErythromycinErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-025ErythromycinErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-075ErythromycinErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-075ErythromycinErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-075ErythromycinErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-075ErythromycinErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
68151-1176ErythromycinErythromycinCarilion Materials ManagementANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
60855SUPPL2019-11-15
60835SUPPL2019-11-14
22254ORIG2016-07-28
39394SUPPL2014-01-31